Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)

Code type

HCPCS Level II

Coverage

Carrier judgment

BETOS category

Z2

Pricing indicator

00

Effective date

20250101